Fungal empyema: an uncommon disease with high mortality
N. Pestana Caires (Lisbon, Portugal), S. Campos Silva (Lisbon, Portugal), J. Eurico Reis (Lisbon, Portugal), R. Gerardo (Lisbon, Portugal), M. Pinto (Lisbon, Portugal), C. Flores (Lisbon, Portugal), J. Cardoso (Lisbon, Portugal)
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Session: Pleural infection and complicated pneumonia
Session type: Poster Discussion
Number: 3844
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Pestana Caires (Lisbon, Portugal), S. Campos Silva (Lisbon, Portugal), J. Eurico Reis (Lisbon, Portugal), R. Gerardo (Lisbon, Portugal), M. Pinto (Lisbon, Portugal), C. Flores (Lisbon, Portugal), J. Cardoso (Lisbon, Portugal). Fungal empyema: an uncommon disease with high mortality. 3844
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Endometriosis-associated pneumothorax: “uncommon” disease Source: International Congress 2019 – Thoracic surgery Year: 2019
Necrotising pneumonia is an increasingly detected complication of pneumonia in children Source: Eur Respir J 2008; 31: 1285-1291 Year: 2008
Polymicrobial empyema has a poor prognosis compared to monomicrobial empyema Source: International Congress 2017 – From microbiology to clinical work Year: 2017
Tuberculous empyema: Risk factors and prognosis Source: International Congress 2015 – Case series and clinical conundrums in TB Year: 2015
Childhood hydatidosis in Belgium: a rare disease with serious complications Source: Eur Respir J 2001; 18: Suppl. 33, 294s Year: 2001
Pulmonary hydatid disease: a unique treatment for an uncommon disease Source: Eur Respir J 2007; 30: Suppl. 51, 392s Year: 2007
Gonococcal pneumonia and endocarditis – a rare presentation of an increasingly common condition Source: Annual Congress 2008 - Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens Year: 2008
Microbial aetiology and outcomes of CAP in bronchiectatic patients Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013
Management of empyema complicating necrotising pneumonia Source: Annual Congress 2009 - Bacterial infections of upper and lower respiratory tract in childhood Year: 2009
Iatrogenic pneumothorax: aetiology and morbidity Source: Eur Respir J 2001; 18: Suppl. 33, 387s Year: 2001
Should empyema be managed differently in case of necrotizing pneumonia? Source: Annual Congress 2013 –Pulmonary infection in children: diagnosis and long-term effects Year: 2013
Pneumonia in children, pleural infection, necrotising pneumonia and lung abscess Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019
Tuberculous (TB) lymphadenitis: risk factors, diagnosis and outcomes in a low TB incidence area Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009
Chylothorax secondary to tuberculous lymphadenitis in the setting of interstitial lung disease: a case report Source: Eur Respir J 2007; 30: Suppl. 51, 441s Year: 2007
Risk factors for pleural complications in children with community acquired pneumonia Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013
Pleural empyema in acute bacterial pneumonia in children Source: Eur Respir J 2004; 24: Suppl. 48, 715s Year: 2004
COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006
Risk factors associated to surgical treatment of parapneumonic effusion and empyema Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections Year: 2013
Risk factors for chronic pulmonary aspergillosis in a low prevalence country and their effect on survival Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015
Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014